Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine for Prevention of CINV in Lung Cancer
NCT03571126Phase 4Unknown
- Sponsor
- Zunyi Medical University
- Start
- May 2019
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of olanzapine in chemotherapy-induced nausea and vomiting (CINV), sponsored by Zunyi Medical University. Status: unknown.
02
Drugs
olanzapine
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT03571126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03571126.